To evaluate long-term safety issues such as myeloproliferative neoplasm (MPN)-like features, we transduced SALL4 isoforms to mouse LSK cells and then performed syngeneic transplantations to allow for long-term follow-up. This evidence concerns the gene SALL4 and myeloproliferative disorder.